Safety and Efficacy of Aliskiren/Amlodipine/Hydrochlorothiazide Triple Combination in Patients With Moderate to Severe Hypertension: A 54‐Week, Open‐Label Study

J Clin Hypertens (Greenwich). 2012; 14:821–827. ©2012 Wiley Periodicals, Inc. Combination antihypertensive therapies are recommended to attain blood pressure (BP) targets especially in high‐risk patients in whom rapid and pronounced BP control is essential. This 28‐ to 54‐week, open‐label, multicent...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Clin Hypertens (Greenwich)
Hauptverfasser: Murray, Alexander V., Koenig, Wolfgang, Garcia‐Puig, Juan, Patel, Samir, PhD, Alkaz Uddin, Zhang, Jack
Format: Artigo
Sprache:Inglês
Veröffentlicht: Blackwell Publishing Ltd 2012
Schlagworte:
Original Papers
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8108980/
https://ncbi.nlm.nih.gov/pubmed/23205748
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1751-7176.2012.00706.x
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge